Media Centre
News

Our client NRGene closed its Initial Public Offering on the Tel Aviv Stock Exchange

Eyal Bar-Zvi Efrat Tzur Ofek Galipoliti

28 January 2021

Our client, the AI genomics company, NRGene, closed its Initial Public Offering on the Tel Aviv Stock Exchange this week and raised NIS 100 million. NRGene develops artificial intelligence solutions that analyze genomics big data to enhance plants’ and animals’ natural breeding processes without genetic engineering. NRGene has already partnered with several leading global companies from 30 countries. We thank our devoted team supporting this start-up, our partners Eyal Bar-Zvi and Efrat Tzur and associates Elina Shechter, Eilon Morag and Ofek Galipoliti. For the article in Globes >> click here

Have a question on this topic? We are here to help

Every case is unique. Let's talk about yours.

Contact Us Now

More News, Insights & Events

Customs and Transfer Pricing: How President Trump’s Tariff Policy Will Affect Israeli Multinationals White Paper: Choosing Between a Delaware Public Benefit Corporation and a Traditional C-Corporation Structure for Generative AI Start-Ups Israel’s AI-Cyber Frontier Report
JOIN OUR
Newsletter

    © 2020, All rights reserved, Herzog Law
    Site by Gootte

    The information contained in this web site is provided for informational purposes only and should not be construed as legal advice on any subject matter and should not be relied upon as such. Herzog accepts no responsibility for any consequences whatsoever arising from use of the information contained in this web site. The accessing of information contained in this web site shall under no circumstances be considered as creating an attorney-client relationship between Herzog and any party accessing this web site. Contacting through email any lawyer named in this web site or sending information without prior agreement of Herzog shall not be construed as automatically creating an attorney-client relationship between Herzog and the party sending an email or information. The material contained in this web site has been created by and remains the property of Herzog. No reproduction, transmission, publication or any other form of dissemination shall be permitted unless the prior written consent of Herzog has been obtained. This web site may contain links to other web sites operated by third parties. Herzog does not sponsor, approve or endorse the content of any such web site and is not responsible for the materials appearing in such sites.